Frequency Of Pd-L1 Positivity And Microsatellite Instability (Msi) In The Dante Trial: Perioperative Atezolizumab With Flot Versus Flot Alone In Patients With Resectable Esophagogastric Adenocarcinoma. A Randomized, Open-Label Phase Iib Trial Of The German Gastric Group At The Aio And Sakk

C. Kopp, S. Lorenzen,T. Gaiser, P. C. Thuss-Patience,M. Schenk, U. Lindig,A. Kretzschmar,V. Heuer,E. Goekkurt, G. M. Haag,J. Riera Knorrenschild, C. Bolling,R. D. Hofheinz,A. R. Siebenhuener,N. Irahara, L. Waberer, C. Pauligk,T. O. Gotze,N. Homann,S-E. Al-Batran

ANNALS OF ONCOLOGY（2021）

引用 3|浏览4

暂无评分

摘要

The DANTE study evaluates atezolizumab in the perioperative treatment of locally advanced, potentially resectable gastric or GEJ adenocarcinoma in combination with FLOT. Here, we report preliminary data for the clinical baseline, along with PD-L1 expression and MSI.

查看译文

关键词

resectable esophagogastric adenocarcinoma,perioperative atezolizumab,microsatellite instability,german esophagogastric group,dante trial,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要